ImmunityBio (IBRX) Treasury Shares (2015 - 2026)

ImmunityBio (IBRX) has 12 years of Treasury Shares data on file, last reported at $5.9 million in Q1 2026.

• On a quarterly basis, Treasury Shares fell 35.63% year-over-year to $5.9 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 35.63% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, up 36.7% from the prior year.
• Treasury Shares for Q1 2026 stood at $5.9 million, down from $8.1 million in the prior quarter.
• Over the last five years, Treasury Shares for IBRX reached as high as $9.2 million in Q1 2025 and fell as low as $163800.0 in Q4 2023.
• Historically, Treasury Shares has averaged $6.4 million across 5 years, with a median of $6.6 million in 2024.
• Across the five-year window, Treasury Shares sank 97.5% in 2023 and surged 4861.95% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $6.6 million in 2022, then sank by 97.5% to $163800.0 in 2023, then changed by 0.0% to $163800.0 in 2024, then jumped by 4861.95% to $8.1 million in 2025, then dropped by 26.9% to $5.9 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $5.9 million in Q1 2026, $8.1 million in Q4 2025, and $8.9 million in Q3 2025.